艾滋病患者中伏立康唑治疗氟康唑耐药念珠菌病的研究 - Suppr

Suppr

超能文献

Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.

作者信息

Hegener P, Troke P F, Fätkenheuer G, Diehl V, Ruhnke M

出版信息

AIDS. 1998 Nov 12;12(16):2227-8.

PMID:9833866

Abstract

摘要

相似文献

Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.艾滋病患者中伏立康唑治疗氟康唑耐药念珠菌病的研究

AIDS. 1998 Nov 12;12(16):2227-8.

[Fluconazole in the treatment of esophageal, bronchial and oral candidiasis in patients with ARC and AIDS].

G Ital Chemioter. 1988 Jan-Dec;35(1-3):61-8.

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.一项关于伏立康唑和氟康唑治疗免疫功能低下患者食管念珠菌病的随机、双盲、双模拟、多中心试验。

Clin Infect Dis. 2001 Nov 1;33(9):1447-54. doi: 10.1086/322653. Epub 2001 Sep 26.

Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.伏立康唑在阴道模型中对氟康唑耐药白色念珠菌分离株的治疗效果。

J Antimicrob Chemother. 2009 Sep;64(3):571-3. doi: 10.1093/jac/dkp228. Epub 2009 Jun 30.

Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.千层白口服溶液治疗艾滋病患者氟康唑难治性口腔念珠菌病的疗效

AIDS. 1998 Jun 18;12(9):1033-7.

Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.头颈部癌放疗患者的口腔念珠菌分离株：患病率、唑类药物敏感性概况及对抗真菌治疗的反应

Oral Microbiol Immunol. 2004 Dec;19(6):347-51. doi: 10.1111/j.1399-302x.2004.00165.x.

Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.艾滋病患者的唑类耐药性口咽和食管念珠菌病。

AIDS. 1995 May;9(5):533-4.

Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.伏立康唑治疗1例获得性免疫缺陷综合征患者的播散性拟青霉感染

Clin Infect Dis. 2002 Oct 1;35(7):e78-81. doi: 10.1086/342302. Epub 2002 Aug 30.

[Resistance of Candida sp. to fluconazole in AIDS patients].[艾滋病患者中念珠菌属对氟康唑的耐药性]

Enferm Infecc Microbiol Clin. 1993 Oct;11(8):462-4.

Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.伏立康唑III期临床研究中，伏立康唑、伊曲康唑、氟康唑和两性霉素B对472例患者的1763株酵母菌的体外活性。

Int J Antimicrob Agents. 2008 Dec;32(6):511-4. doi: 10.1016/j.ijantimicag.2008.05.023. Epub 2008 Sep 13.

引用本文的文献

Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.耳蜗内两性霉素 B 在小鼠和人体黏膜念珠菌病中的疗效。

Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0030822. doi: 10.1128/aac.00308-22. Epub 2022 Jun 14.

Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated Pharmacokinetic/Pharmacodynamic Model.采用验证的药代动力学/药效学模型，实现白念珠菌伏立康唑 CLSI 和 EUCAST 折点的协调统一。

Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.00170-20.

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.《念珠菌病管理临床实践指南：美国传染病学会2016年更新版》

Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.

Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066).HIV 感染者机会性感染的治疗和预防：德国和奥地利艾滋病协会（DAIG/ÖAG）指南（AWMF 055/066）。

Infection. 2013 Sep;41 Suppl 2(Suppl 2):S91-115. doi: 10.1007/s15010-013-0504-1. Epub 2013 Sep 14.

Validated LC Method for the Estimation of Voriconazole in Bulk and Formulation.用于原料药和制剂中伏立康唑测定的验证液相色谱法。

Indian J Pharm Sci. 2009 Nov;71(6):699-702. doi: 10.4103/0250-474X.59558.

Oropharyngeal candidiasis in the era of antiretroviral therapy.抗逆转录病毒治疗时代的口腔念珠菌病

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Apr;109(4):488-95. doi: 10.1016/j.tripleo.2009.11.026. Epub 2010 Feb 13.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.念珠菌病管理临床实践指南：美国传染病学会2009年更新版

Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757.

Voriconazole in the management of nosocomial invasive fungal infections.伏立康唑在医院获得性侵袭性真菌感染中的应用。

Ther Clin Risk Manag. 2006 Jun;2(2):129-58. doi: 10.2147/tcrm.2006.2.2.129.

Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.伏立康唑以碾碎片或整片口服给药的比较药代动力学。

Antimicrob Agents Chemother. 2007 Mar;51(3):877-80. doi: 10.1128/AAC.01263-06. Epub 2006 Dec 4.

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.针对念珠菌属对伏立康唑的药敏试验，最小抑菌浓度（MIC）与结果的相关性分析及解释性折点建议

J Clin Microbiol. 2006 Mar;44(3):819-26. doi: 10.1128/JCM.44.3.819-826.2006.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验